|Bid||31.76 x 800|
|Ask||31.79 x 1300|
|Day's Range||30.51 - 32.88|
|52 Week Range||23.20 - 71.91|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 13, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||51.60|
AbCellera Reports Q1 2021 Business Results
AbCellera stock tumbled Friday, despite in-line royalties for its Lilly-partnered Covid drug. Here's why the stock toppled.
Image source: The Motley Fool. AbCellera Biologics Inc. (NASDAQ: ABCL)Q1 2021 Earnings CallMay 13, 2021, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day and thank you for standing by.